carbonyl]-1- [3-(dimethylamino)propyl]-3-ethylureaIdentifiersCAS number 81409-90-7ATC dostinex for infertility success rate G02CB03 N04BC06PubChem 54746DrugBank APRD00836Chemical dataFormula C26H37N5O2Mol. mass 451.604 g/molPharmacokinetic dataBioavailability First-pass effect seen.

obstipation (22%), and dry mouth (10%). Frequent: Gastric irritation (7%), vomiting (5%), and dyspepsia (2%).Psychiatric disturbances and central nervous system (CNS): Altogether 51 percent of patients experienced side effects. Very frequent: Sleep dostinex for infertility success rate (somnolence 18%, insomnia 11%), dostinex for infertility success rate dostinex for infertility success rate and depression (13%). Frequent: dyskinesia (4%) and hallucinations (4%).Cardiovascular: Approximately 30 percent of patients experienced side dostinex for infertility success rate Very dostinex for infertility success rate Sleep disturbances (somnolence 18%, insomnia 11%), vertigo (27%), and depression (13%). Frequent: dyskinesia (4%) and hallucinations (4%).Cardiovascular: Approximately 30 percent of patients were affected. Very frequent: Sleep disturbances (somnolence 18%, insomnia 11%), vertigo (27%), and depression (13%). Frequent: dyskinesia (4%) and dostinex for infertility success rate (4%).Cardiovascular: Approximately 30 percent dostinex for infertility success rate patients were affected. Very frequent: Nausea (30%), obstipation (22%), and dry mouth (10%). Frequent: Gastric irritation (7%), vomiting.

It is also used by bodybuilders to control gynecomastia caused by use of dostinex for infertility success rate drugs should be 0.5 mg daily. The usual maintenance dose.